Autologous stem cell transplantation for advanced Hodgkin's disease in children

Bone Marrow Transplantation

Volumn 25, Issue 1, 2000, Pages 31-34

  Verdeguer, A ^a   Pardo, N ^b   Madero, L ^c   Martinez, A ^d   Bureo, E ^e   Fernandez J M ^a   Munoz A ^f   Olive T ^g   Fernandez Delgado R ^h   Cubells, J ^b   Diaz, M A ^c   Sastre, A ^d  

^a HOSPITAL INFANTIL LA FE   (Spain)

^b Hospital St Pau   (Spain)

^c HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^f HOSPITAL RAMÓN Y CAJAL   (Spain)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Advanced HD; ASCT; Hodgkin's disease in children

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINCRISTINE SULFATE;

ADOLESCENT; ADULT; ARTICLE; AUTOTRANSPLANTATION; CHILD; CLINICAL ARTICLE; FEMALE; HODGKIN DISEASE; HUMAN; MALE; MULTIPLE ORGAN FAILURE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION; SEPSIS; STEM CELL TRANSPLANTATION; SURVIVAL TIME; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 0033952080     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702094     Document Type: Article

References (21)

1. Reece DE, Connors JM, Spinelli JJ et al. Intensive therapy with cyclophosphamide, carmustine, etoposide ± cisplatin and autologous hone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy. Blood 1994; 83: 1193-1199.
2. Nademanee A, O'Donnell MR. Synder DS et al. High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors. Blood 1995; 85: 1381-1390.
3. Biermann PJ, Anderson JR, Freeman MB et al. High-dose chemotherapy followed by autologous hemutopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy. Ann Oncol 1996; 7: 151-156.
4. Horning SJ, Chao NJ, Negrin RS et al. High-dose therapy and autologous hematopoietic progenitor cell transplant for recurrent or refractory Hodgkin's disease: analysis of Stanford University results and prognostic indices. Blood 1997; 89: 801-813.
5. Yuen AR, Rosenberg SA, Hoppe RT et al. Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. Blood 1997; 89: 814-822.
6. Burns LJ, Daniels KA, McGlave PB. Autologous stem cell transplantation for refractory and relapsed Hodgkin's disease: factors predictive of prolonged survival. Bone Marrow Transplant 1995; 16: 13-18.
7. Carella AM, Prencipe E, Pungolino E et al. Twelve years' experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD protocol. Leuk Lymphoma 1996; 21: 63-70.
8. Fleurys J, Legros M, Colombart P et al. High-dose therapy and autologous bone marrow transplantation in first complete remission or partial response for poor prognosis Hodgkin's disease. Leuk Lymphoma 1996; 20: 259-266.
9. Bradley SJ, Pearce R, Taghipour G et al. First remission autologous bone marrow transplantation for Hodgkin's disease. Preliminary EBMT data. Leuk Lymphoma 1996; 15(Suppl. 1): 51-53.
10. Sureda A, Mataix R, Hernández-Navarro F et al. Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission. A retrospective study from the Spanish GEL-TAMO cooperative group. Bone Marrow Transplant 1997; 20: 283-288.
11. Hutchinson RJ, Fryer CJH, Davis PCh. MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group phase III trial. J Clin Oncol 1998; 16: 897-906.
12. Hunger SP, Link MP, Donaldson SS. ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience. J Clin Oncol 1994; 12: 2160-2166.
13. Bonfante V, Santoro A, Viviani S et al. Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD. J Clin Oncol 1997; 15: 528-534.
14. Arranz, R, Tomás JF, Gil-Fernández JJ et al. Autologous stem cell transplantation (ASCT) for poor prognostic Hodgkin's disease (HD): comparative results with two CBV regimens and importance of disease status at transplant. Bone Marrow Transplant 1998; 21: 779-786.
15. Crump M, Smith AM. Brandwein J et al. High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant. J Clin Oncol 1993; 11: 704-711.
16. Baker KS, Gordon BG, Gross TG et al. Autologous hematopoietic stem-cell transplantation for relapsed or refractory Hodgkin's disease in children and adolescents. J Clin Oncol 1999; 17: 825-831.
17. Moreau P, Fleury J, Brice P et al. Early intensive therapy with autologous stem cell transplantation in advanced Hodgkin's disease: retrospective analysis of 158 cases from the French registry. Bone Marrow Transplant 1998; 21: 787-793.
18. Sankila R, Garvicz S, Olsen JH et al. Risk of subsequent malignant neoplasms among 1641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. J Clin Oncol 1896; 14: 1442-1446.
19. Wolden SL, Lamborn KR, Cleary SF. Second cancers following pediatric Hodgkin's disease. J Clin Oncol 1998; 16: 536-544.
20. Miller JS, Arthur DC, Litz CE et al. Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood 1994; 83: 3780-3786.
21. Chopra R, McMillan AK, Linch DC et al. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single center eight-year study of 155 patients. Blood 1993; 81: 1137-1145.